Injective (INJ) is showing a potentially bullish setup as traders watch for a breakout from a key liquidity zone. At the same time, the network's expanding real-world asset (RWA) tokenization, artificial intelligence, and compliance infrastructure are strengthening its appeal for institutional financial applications.

Injective is a Layer 1 blockchain built specifically for finance, designed to support applications ranging from decentralized trading and derivatives to tokenized real-world assets.

At the time of writing, INJ is trading at $5.04, with a 24-hour trading volume of $121.79 million and a market capitalization of $504.09 million, according to CoinMarketCap. Following a 5.78% gain over the last 24 hours, the token's price structure and network growth point to a bullish reversal ahead.

INJ Price Setup Signals Potential Breakout to $60

Crypto analyst @TakeProfitNow, posting on X, reported that Injective is attracting renewed attention after entering a major liquidity zone that had previously preceded a massive rally. From comparable levels, the token delivered an extraordinary 3,100% advance, underscoring its ability to generate explosive moves whenever market momentum shifts. With sentiment subdued and consolidation extended, that zone is now back on traders' radar.

The scale of the call is worth noting: at $5.04, the $60 target implies a roughly twelvefold move that would take INJ above its all-time high of about $52.60, set in March 2024, and into record territory.

According to the analyst, another breakout could mark the beginning of yet another round of significant uptrends, especially in light of the improved environment across the broader crypto market. While history never repeats itself, previous reactions from this zone give the bull case some weight — and in the analyst's view, it is now just a matter of time until INJ makes its way to $60.

Injective Eyes Institutional Growth Through RWA

Newly shared data from Injective highlighted that the network has made tangible progress toward real-world asset tokenization through the use of RWA infrastructure, artificial intelligence, and compliance capabilities on a single blockchain.

The update arrives as tokenization moves from experiment toward mainstream finance, with asset managers including BlackRock and Franklin Templeton having launched tokenized funds and Boston Consulting Group projecting the tokenized asset market could reach roughly $16 trillion by 2030.

A pilot program undertaken by POSCO International and LG CNS incorporated actual trade data alongside commercial invoices, with artificial intelligence analyzing letters of credit and compliance built into the infrastructure itself. The partners bring established credentials to the trial: POSCO International is the trading arm of South Korean steel group POSCO, while LG CNS is the IT services affiliate of LG.

In addition, Injective has now registered with the SEC as a transfer agent, a step that increases the platform's ability to provide services within regulated financial markets. In US securities infrastructure, transfer agents maintain the register of who owns a security and process ownership changes, so the registration plugs Injective directly into the mechanics of regulated issuance. The blockchain has tokenized a variety of instruments to date, ranging from institutional assets, public stocks, and trade receivables to pre-IPO offerings that include firms such as SpaceX and OpenAI.

What Comes Next for Injective?

Injective's next steps depend on the outcome of INJ pushing through its resistance levels and sustaining buying pressure. A confirmed breakout would add impetus to the rise toward $60, while a stretch of further consolidation would push the rally back. Even so, the continued build-out of RWA tokenization, AI development, and institutional infrastructure may help Injective maintain momentum in the future.

Beyond the chart, the milestones to watch are whether the POSCO International and LG CNS pilot progresses beyond its trial phase, whether additional tokenized offerings follow the transfer agent registration, and how Injective's asset lineup stands up as major financial firms expand tokenization programs of their own.

This article contains market analysis and price predictions, which are not guarantees. Crypto markets are volatile. Always do your own research (DYOR). Not financial advice.